InDex Pharmaceuticals Holding AB (publ)
SSE:INDEX.ST
0.244 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 97.505 | 1.146 | 0.44 | 0.035 | 0.088 | 0.128 | 0.113 | 0.176 | 0.376 | 45.16 |
| Cost of Revenue
| 193.213 | 10.287 | 14.383 | 16.021 | 3.903 | 0.56 | 8.998 | 6.301 | 1.422 | 4.994 |
| Gross Profit
| -95.708 | -9.141 | -13.943 | -15.986 | -3.815 | -0.432 | -8.885 | -6.125 | -1.046 | 40.166 |
| Gross Profit Ratio
| -0.982 | -7.976 | -31.689 | -456.743 | -43.352 | -3.375 | -78.628 | -34.801 | -2.782 | 0.889 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 87.737 | 30.99 | 70.189 | 78.981 | 54.825 | 24.313 | 19.511 | 40.924 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 187.839 | 150.048 | 87.737 | 30.99 | 70.189 | 78.981 | 54.825 | 24.313 | 19.511 | 40.924 |
| Other Expenses
| 0 | 139.681 | 13.07 | 10.373 | 13.708 | 8.952 | 9.605 | 9.111 | 8.917 | 11.428 |
| Operating Expenses
| 200.715 | 139.681 | 100.807 | 41.363 | 83.897 | 87.933 | 64.43 | 33.424 | 28.428 | 52.352 |
| Operating Income
| -95.708 | -103.227 | -102.91 | -57.349 | -87.712 | -82.365 | -73.315 | -39.549 | -29.474 | -12.186 |
| Operating Income Ratio
| -0.982 | -90.076 | -233.886 | -1,638.543 | -996.727 | -643.477 | -648.805 | -224.71 | -78.388 | -0.27 |
| Total Other Income Expenses Net
| 0.443 | 49.635 | 12.147 | -0.069 | -0.061 | 0.05 | 0.556 | -1.726 | -0.407 | -2.684 |
| Income Before Tax
| -95.265 | -100.333 | -103.043 | -57.418 | -87.773 | -82.315 | -72.759 | -41.275 | -29.881 | -10.395 |
| Income Before Tax Ratio
| -0.977 | -87.551 | -234.189 | -1,640.514 | -997.42 | -643.086 | -643.885 | -234.517 | -79.471 | -0.23 |
| Income Tax Expense
| 0 | -2.894 | 0.133 | 0.113 | 0.061 | 6.056 | 0.596 | -0.022 | 0.006 | 4.475 |
| Net Income
| -95.265 | -97.439 | -103.176 | -57.531 | -87.834 | -82.315 | -72.759 | -41.275 | -29.881 | -14.87 |
| Net Income Ratio
| -0.977 | -85.025 | -234.491 | -1,643.743 | -998.114 | -643.086 | -643.885 | -234.517 | -79.471 | -0.329 |
| EPS
| -0.18 | -0.18 | -0.21 | -0.24 | -0.45 | -0.18 | -0.44 | -0.41 | -0.37 | -0.093 |
| EPS Diluted
| -0.18 | -0.18 | -0.21 | -0.24 | -0.45 | -0.18 | -0.44 | -0.41 | -0.37 | -0.093 |
| EBITDA
| -93.821 | -150.048 | -114.378 | -56.113 | -86.773 | -82.298 | -72.708 | -39.504 | -29.373 | -10.283 |
| EBITDA Ratio
| -0.969 | -86.516 | -231.041 | -1,603.229 | -986.057 | -642.953 | -643.434 | -224.455 | -78.12 | -0.228 |